암치료
The Repurposing Drugs in Oncology (ReDO) Project
unicircle
2021. 8. 22. 16:55
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096030/
https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4096024/
https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4720497/
https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5102691/
https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4406527/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341996/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268104/
Table 1.
The first six drugs to be assessed by the ReDO project
DrugTypeExisting IndicationAvailability
| Mebendazole | Anthelminthic | Threadworm infections | Generic |
| Nitroglycerin | Vasodilator | Angina | Generic |
| Cimetidine | H2-receptor antagonist | Peptic ulcer | Generic |
| Clarithromycin | Antibiotic | Respiratory tract infection | Generic |
| Diclofenac | NSAID | Pain relief | Generic |
| Itraconazole | Antifungal | Broad spectrum antifungal | Generic |